<DOC>
	<DOCNO>NCT02305446</DOCNO>
	<brief_summary>The purpose trial ass safety Meningococcal Group B Vaccine collect blood donation . Sera panel obtain blood donation use control measure immunoresponse Meningococcal Group B Vaccine study .</brief_summary>
	<brief_title>Safety Blood Donations Adults Vaccinated With rMenB+OMV NZ .</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Individuals 18 50 year age day inform consent ; 2 . Individuals voluntarily give write informed consent nature study explain accord local regulatory requirement , prior study entry ; 3 . Individuals could comply study procedure include followup ; 4 . Males , female nonchildbearing potential female childbearing potential use effective birth control method . 1 . Progressive , unstable uncontrolled clinical condition ; 2 . Hypersensitivity , include allergy , component vaccine medical equipment whose use foreseen study ; 3 . Abnormal function immune system ; 4 . Chronic clinical significant condition ; 4 . Been administer group B meningococcal vaccine time prior informed consent ; 5 . Current previous , confirm suspected disease cause N.meningitidis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>